7
CDC Clinical Reminder: “Use of Fingerstick Devices on More
than One Person Poses Risk for Transmitting Bloodborne
Pathogens” (2010)
http://www.cdc.gov/injectionsafety/Fingerstick-DevicesBGM.html.
Intended use
The OneTouch Verio IQ® Blood Glucose Monitoring System
is intended to be used for the quantitative measurement of
glucose (sugar) in fresh capillary whole blood samples drawn
from the fingertips. The system is intended to be used by a
single patient and should not be used for testing multiple
patients.
The OneTouch Verio IQ® Blood Glucose Monitoring System is
intended for self-testing outside the body (in vitro diagnostic
use) by people with diabetes at home as an aid to monitor
the effectiveness of diabetes control.
The OneTouch Verio IQ® Blood Glucose Monitoring System is
not to be used for the diagnosis of or screening of diabetes
or for neonatal use.
Not for use on critically ill patients, patients in shock,
dehydrated patients or hyperosmolar patients.
